$ARAT
Arax Holdings Corp Stock $arat

$arat Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000175392624001561 Filed on September 11, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue		$301.8K	$226.9K
YoY Change		33.0%
Cost Of Revenue
YoY Change
Gross Profit		$301.8K
YoY Change		33.0%
Gross Profit Margin		100.0%
Selling, General & Admin	$329.8K	$87.54K	$70.40K
YoY Change	-13.06%	-92.76%	-30.18%
% of Gross Profit		29.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$151.00	$151.00
YoY Change
% of Gross Profit		0.05%
Operating Expenses	$329.8K	$87.54K	-$3.084M
YoY Change	-87.14%	-92.76%	-3158.36%
Operating Profit	-$329.8K	$214.2K
YoY Change	-85.88%	-121.83%
Interest Expense	-$103.4K	-$887.00
YoY Change		-96.93%
% of Operating Profit		-0.41%
Other Income/Expense, Net	$101.00		-$80.00
YoY Change	-99.97%
Pretax Income	-$433.3K	$213.3K	-$15.24M
YoY Change	-78.35%	-179.51%	15014.29%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$433.3K	$213.3K	-$15.24M
YoY Change	-53589.63%	-1735.07%	15014.29%
Net Earnings / Revenue		70.7%	-6716.8%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$0.09
COMMON SHARES
Basic Shares Outstanding	129.6M shares	127.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.17K	$95.09K	$1.449M
YoY Change
Cash & Equivalents	$12.17K	$95.09K	$1.449M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$755.6K	$755.6K	$227.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$767.8K	$850.7K	$1.676M
YoY Change	488.24%	56.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.057K	$1.208K	$1.510K
YoY Change
Goodwill
YoY Change
Intangibles	$268.0K	$268.0K	$268.0K
YoY Change
Long-Term Investments			$437.4K
YoY Change
Other Assets	$169.4K	$169.4K	$0.00
YoY Change
Total Long-Term Assets	$6.844M	$6.737M	$5.472M
YoY Change	-64.9%	-64.55%
TOTAL ASSETS
Total Short-Term Assets	$767.8K	$850.7K	$1.676M
Total Long-Term Assets	$6.844M	$6.737M	$5.472M
Total Assets	$7.612M	$7.588M	$7.148M
YoY Change	-61.22%	-61.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$137.2K	$181.2K	$100.0K
YoY Change		11052.18%
Accrued Expenses	$200.9K	$114.4K	$100.4K
YoY Change	17.44%	163.56%	-14.11%
Deferred Revenue
YoY Change
Short-Term Debt	$11.00K	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$506.9K	$453.3K	$258.1K
YoY Change	121.51%	3.62%	47.82%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$506.9K	$453.3K	$258.1K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$506.9K	$453.3K	$258.1K
YoY Change	121.51%	-52.58%	47.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.50M	-$23.07M	-$19.42M
YoY Change	458.89%	946.91%	2109.61%
Common Stock	$12.83K	$12.78K	$126.2K
YoY Change	-89.09%	-88.33%	1120.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.105M	$7.134M	$6.890M
YoY Change
Total Liabilities & Shareholders Equity	$7.612M	$7.588M	$7.148M
YoY Change	-61.22%	-61.18%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$433.3K	$213.3K	-$15.24M
YoY Change	-53589.63%	-1735.07%	15014.29%
Depreciation, Depletion And Amortization	$151.00	$151.00
YoY Change
Cash From Operating Activities	-$286.4K	-$2.940K	-$14.95M
YoY Change	-88.25%	-99.75%
INVESTING ACTIVITIES
Capital Expenditures	$107.5K	$0.00	$5.033M
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$18.55M
YoY Change
Cash From Investing Activities	-$107.5K	$0.00	$13.52M
YoY Change	-59.89%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	311.0K	95.00K	2.716M
YoY Change	-86.43%	-99.53%
NET CHANGE
Cash From Operating Activities	-286.4K	-2.940K	-14.95M
Cash From Investing Activities	-107.5K	0.000	13.52M
Cash From Financing Activities	311.0K	95.00K	2.716M
Net Change In Cash	-82.92K	92.06K	1.286M
YoY Change	-79.89%	-83.19%
FREE CASH FLOW
Cash From Operating Activities	-$286.4K	-$2.940K	-$14.95M
Capital Expenditures	$107.5K	$0.00	$5.033M
Free Cash Flow	-$393.9K	-$2.940K	-$19.98M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127753215	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-183926	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1066865	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1250791	usd
CY2023Q2	arat	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition	18000000	usd
CY2023Q2	arat	Issuance Of Common Stock Upon Conversion Of Convertible Promissory Notes IssuanceOfCommonStockUponConversionOfConvertiblePromissoryNotes	1100466	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1959108	usd
CY2023Q2	arat	Issuance Of Common Stock In Conversion Of Convertible Notes Related To Acquisition IssuanceOfCommonStockInConversionOfConvertibleNotesRelatedToAcquisition	550285	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1959108	usd
CY2023Q2	arat	Issuance Of Common Stock In Conversion Of Convertible Notes Related To Acquisition IssuanceOfCommonStockInConversionOfConvertibleNotesRelatedToAcquisition	550285	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1791316	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18567751	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6789801	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	721862	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1791316	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18567751	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6789801	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	721862	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-685994	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-685994	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6825669	usd
CY2024Q2	arat	Issuance Of Common Stock Upon Conversion Of Convertible Notes IssuanceOfCommonStockUponConversionOfConvertibleNotes	95376	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6825669	usd
CY2024Q2	arat	Issuance Of Common Stock Upon Conversion Of Convertible Notes IssuanceOfCommonStockUponConversionOfConvertibleNotes	95376	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	213328	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	213328	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7134372	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-472666	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-472666	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2858181	usd
	arat	Debt Issuance Cost Of Amortization DebtIssuanceCostOfAmortization	377	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	721862	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1959107	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	713136	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	528636	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	95203	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2858181	usd
	us-gaap	Depreciation Depreciation	302	usd
	arat	Debt Issuance Cost Of Amortization DebtIssuanceCostOfAmortization	377	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	721862	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1959107	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	713136	usd
	arat	Amortization Of Debt Discount Related To Derivative AmortizationOfDebtDiscountRelatedToDerivative	1047879	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	528636	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	453772	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Other Expenses OtherExpenses		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	arat	Reduction Of Common Stock To Be Issued For Acquisition ReductionOfCommonStockToBeIssuedForAcquisition		usd
CY2024Q2	arat	Reduction Of Common Stock To Be Issued For Acquisition ReductionOfCommonStockToBeIssuedForAcquisition		usd
	us-gaap	Depreciation Depreciation		usd
	arat	Debt Issuance Cost Of Amortization DebtIssuanceCostOfAmortization		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	arat	Amortization Of Debt Discount Related To Derivative AmortizationOfDebtDiscountRelatedToDerivative		usd
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Notes Reduction NotesReduction		usd
	us-gaap	Notes Assumed1 NotesAssumed1		usd
	us-gaap	Notes Issued1 NotesIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	us-gaap	Depreciation Depreciation		usd
	us-gaap	Depreciation Depreciation		usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2024Q2	arat	Fair Value Of Derivative Liability Term FairValueOfDerivativeLiabilityTerm	P2Y6M
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Notes Payable NotesPayable		usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	arat	Increase Decrease In Derivative Interest IncreaseDecreaseInDerivativeInterest		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-04-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-185928
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Other Expenses OtherExpenses		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	arat	Reduction Of Common Stock To Be Issued For Acquisition ReductionOfCommonStockToBeIssuedForAcquisition		usd
CY2024Q2	arat	Reduction Of Common Stock To Be Issued For Acquisition ReductionOfCommonStockToBeIssuedForAcquisition		usd
	us-gaap	Depreciation Depreciation		usd
	arat	Debt Issuance Cost Of Amortization DebtIssuanceCostOfAmortization		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	arat	Amortization Of Debt Discount Related To Derivative AmortizationOfDebtDiscountRelatedToDerivative		usd
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Notes Reduction NotesReduction		usd
	us-gaap	Notes Assumed1 NotesAssumed1		usd
	us-gaap	Notes Issued1 NotesIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	us-gaap	Depreciation Depreciation		usd
	us-gaap	Depreciation Depreciation		usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2024Q2	arat	Fair Value Of Derivative Liability Term FairValueOfDerivativeLiabilityTerm	P2Y6M
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Notes Payable NotesPayable		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	arat	Increase Decrease In Derivative Interest IncreaseDecreaseInDerivativeInterest		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-04-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-185928
	dei	Entity Registrant Name EntityRegistrantName	ARAX HOLDINGS CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	99-0376721
	dei	Entity Address Address Line1 EntityAddressAddressLine1	820 E Park Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Blvd D200
	dei	Entity Registrant Name EntityRegistrantName	ARAX HOLDINGS CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	99-0376721
	dei	Entity Address Address Line1 EntityAddressAddressLine1	820 E Park Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Blvd D200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tallahassee
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32301
	dei	Local Phone Number LocalPhoneNumber	254-1161
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	129613930	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1448769	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	226951	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1675720	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	381	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	79	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1510	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5033332	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	169373	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Assets Assets	7147935	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	100000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100378	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	157756	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	358134	usd
CY2024Q2	us-gaap	Liabilities Liabilities	453339	usd
CY2023Q4	us-gaap	Liabilities Liabilities	358134	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	10000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	10000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127753215	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126160534	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	12775	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12616	usd
CY2024Q2	arat	Common Stock To Be Issue CommonStockToBeIssue	900000	usd
CY2023Q4	arat	Common Stock To Be Issue CommonStockToBeIssue	1440000	usd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tallahassee
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32301
	dei	City Area Code CityAreaCode	850
	dei	Local Phone Number LocalPhoneNumber	254-1161
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	129613930	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1448769	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	755587	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	226951	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	850678	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1675720	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1208	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1510	usd
CY2024Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	6298452	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5033332	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	169373	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	169373	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Assets Assets	7147935	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	181223	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	100000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100378	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	157756	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	453339	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	358134	usd
CY2023Q4	us-gaap	Liabilities Liabilities	358134	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127753215	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126160534	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126160534	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	12775	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12616	usd
CY2024Q2	arat	Common Stock To Be Issue CommonStockToBeIssue	900000	usd
CY2023Q4	arat	Common Stock To Be Issue CommonStockToBeIssue	1440000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29278076	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27920998	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23066479	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22593813	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7134372	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6789801	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29278076	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27920998	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23066479	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22593813	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7134372	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6789801	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7147935	usd
CY2024Q2	us-gaap	Revenues Revenues	301750	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	528636	usd
	us-gaap	Revenues Revenues	453772	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	301750	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	226886	usd
	us-gaap	Gross Profit GrossProfit	528636	usd
	us-gaap	Gross Profit GrossProfit	453772	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87535	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	743341	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	278554	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	988463	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	87535	usd
	us-gaap	Operating Expenses OperatingExpenses	1000415	usd
	us-gaap	Operating Expenses OperatingExpenses	2947570	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	214215	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2475562	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-472364	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2522688	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-887	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-887	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-887	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	213328	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	213328	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127403068	shares
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7587711	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7147935	usd
CY2024Q2	us-gaap	Revenues Revenues	301750	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	453772	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	301750	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	226886	usd
	us-gaap	Gross Profit GrossProfit	528636	usd
	us-gaap	Gross Profit GrossProfit	453772	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87535	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	743341	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	278554	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	988463	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	721861	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	87535	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2702448	usd
	us-gaap	Operating Expenses OperatingExpenses	1000415	usd
	us-gaap	Operating Expenses OperatingExpenses	2947570	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	214215	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2475562	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-472364	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2522688	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-887	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-887	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	-713136	usd
	us-gaap	Other Expenses OtherExpenses	335493	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-887	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	684246	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-887	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-364383	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	213328	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1791316	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2858181	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	213328	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1791316	usd
	us-gaap	Profit Loss ProfitLoss	-2858181	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127403068	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24564538	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126846644	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17291813	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-183926	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1066865	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1250791	usd
CY2023Q2	arat	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition	18000000	usd
CY2023Q2	arat	Issuance Of Common Stock Upon Conversion Of Convertible Promissory Notes IssuanceOfCommonStockUponConversionOfConvertiblePromissoryNotes	1100466	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	95203	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13435	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-183558	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1004667	usd
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	1265120	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1265120	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	95000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1539010	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1539010	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1353678	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	534343	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	95091	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	534343	usd
	us-gaap	Notes Reduction NotesReduction	540000	usd
	us-gaap	Notes Assumed1 NotesAssumed1	95376	usd
	us-gaap	Notes Issued1 NotesIssued1	1091164	usd
	us-gaap	Stock Issued1 StockIssued1	18550285	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_847_eus-gaap--NatureOfOperations_z1gSL3HrKbfe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><i><span id="xdx_861_zlZURgaPw1Fh">General</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">Arax Holdings Corp. (“the Company”) is a <span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20231101__20240430__srt--OwnershipAxis__custom--AraxHoldingsCorpMember_zHEJZUb4kWo9" title="Entity incorporation, state or country code">Nevada</span> corporation incorporated on <span id="xdx_90E_edei--EntityIncorporationDateOfIncorporation_c20231101__20240430__srt--OwnershipAxis__custom--AraxHoldingsCorpMember_zFl6UI4Krb76" title="Entity incorporation date">February 23, 2012</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company currently has operations from a growing business in the software development and integration marketplace.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">Management intends to explore and identify business opportunities within North America, Europe, Asia and Africa including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction. Our executives have experience in business consulting, although no assurances can be given that they can identify and implement a viable business strategy or that any such strategy will result in profits. Our ability to effectively identify, develop and implement a viable plan for our business may be hindered by risks and uncertainties which are beyond our control, including without limitation, the continued negative effects of the coronavirus pandemic on the U.S. and global economies.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z3S4Ss6Mi8qi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i><span id="xdx_863_zN8varEJHxJ5">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results and outcomes may differ from management’s estimates and assumptions. Included in these estimates are assumptions used to estimate collection of accounts receivable, fair value of intangible assets, fair value of capitalized software, deferred income tax asset valuation allowances.</p>
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13435	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-183558	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1004667	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1265120	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1539010	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1539010	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1353678	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	534343	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1448769	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	95091	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	534343	usd
	us-gaap	Notes Reduction NotesReduction	540000	usd
	us-gaap	Notes Assumed1 NotesAssumed1	95376	usd
	us-gaap	Notes Issued1 NotesIssued1	1091164	usd
	us-gaap	Stock Issued1 StockIssued1	18550285	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_847_eus-gaap--NatureOfOperations_z1gSL3HrKbfe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><i><span id="xdx_861_zlZURgaPw1Fh">General</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">Arax Holdings Corp. (“the Company”) is a <span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20231101__20240430__srt--OwnershipAxis__custom--AraxHoldingsCorpMember_zHEJZUb4kWo9" title="Entity incorporation, state or country code">Nevada</span> corporation incorporated on <span id="xdx_90E_edei--EntityIncorporationDateOfIncorporation_c20231101__20240430__srt--OwnershipAxis__custom--AraxHoldingsCorpMember_zFl6UI4Krb76" title="Entity incorporation date">February 23, 2012</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company currently has operations from a growing business in the software development and integration marketplace.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">Management intends to explore and identify business opportunities within North America, Europe, Asia and Africa including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction. Our executives have experience in business consulting, although no assurances can be given that they can identify and implement a viable business strategy or that any such strategy will result in profits. Our ability to effectively identify, develop and implement a viable plan for our business may be hindered by risks and uncertainties which are beyond our control, including without limitation, the continued negative effects of the coronavirus pandemic on the U.S. and global economies.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z3S4Ss6Mi8qi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i><span id="xdx_863_zN8varEJHxJ5">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results and outcomes may differ from management’s estimates and assumptions. Included in these estimates are assumptions used to estimate collection of accounts receivable, fair value of intangible assets, fair value of capitalized software, deferred income tax asset valuation allowances.</p>
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Depreciation Depreciation	151	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Depreciation Depreciation	151	usd
	us-gaap	Depreciation Depreciation	302	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zclKadX5lG13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i><span id="xdx_86C_z0PwikTYqrT7">Concentration of Credit Risk and Significant Customers and Vendors</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of April 30, 2024, and October 31, 2023 one customer accounted for all of the accounts receivable balance.</p>
	us-gaap	Depreciation Depreciation	302	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zclKadX5lG13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i><span id="xdx_86C_z0PwikTYqrT7">Concentration of Credit Risk and Significant Customers and Vendors</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of April 30, 2024, and October 31, 2023 one customer accounted for all of the accounts receivable balance.</p>
	us-gaap	Derivative Excluded Component Loss Recognized In Earnings DerivativeExcludedComponentLossRecognizedInEarnings	1047879	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-707166	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	340713	usd
CY2024Q2	arat	Stock Price On Valuation Date StockPriceOnValuationDate	1.0
CY2024Q2	us-gaap	Derivative Floor Interest Rate DerivativeFloorInterestRate	0.003	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	3.10
CY2024Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.2
	us-gaap	Derivative Excluded Component Loss Recognized In Earnings DerivativeExcludedComponentLossRecognizedInEarnings	1047879	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-707166	usd
CY2024Q2	arat	Stock Price On Valuation Date StockPriceOnValuationDate	1.0
CY2024Q2	us-gaap	Derivative Floor Interest Rate DerivativeFloorInterestRate	0.003	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	3.10
CY2024Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.2
	us-gaap	Derivatives Methods Of Accounting Hedge Documentation DerivativesMethodsOfAccountingHedgeDocumentation	<p id="xdx_841_eus-gaap--DerivativesMethodsOfAccountingHedgeDocumentation_zQ9O4SKZ1378" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i><span id="xdx_868_zkfxCpLEaWBj">Convertible Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">ASC 480 “<i>Distinguishing Liabilities From Equity</i>” provides that instruments convertible predominantly at a fixed rate resulting in a fixed monetary amount due upon conversion with a variable quantity of shares (“stock settled debt”) be recorded as a liability at the fixed monetary amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">ASC 815 “<i>Derivatives and Hedging</i>” generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">ASC 815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract shall be classified as an asset or a liability.</p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2185810	shares
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1185810	usd
	us-gaap	Derivatives Methods Of Accounting Hedge Documentation DerivativesMethodsOfAccountingHedgeDocumentation	<p id="xdx_841_eus-gaap--DerivativesMethodsOfAccountingHedgeDocumentation_zQ9O4SKZ1378" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i><span id="xdx_868_zkfxCpLEaWBj">Convertible Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">ASC 480 “<i>Distinguishing Liabilities From Equity</i>” provides that instruments convertible predominantly at a fixed rate resulting in a fixed monetary amount due upon conversion with a variable quantity of shares (“stock settled debt”) be recorded as a liability at the fixed monetary amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">ASC 815 “<i>Derivatives and Hedging</i>” generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #212529">ASC 815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract shall be classified as an asset or a liability.</p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2185810	shares
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1185810	usd
CY2024Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	1000000	usd
CY2023Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	1000000	usd
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	1000000	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	2185810	usd
CY2024Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	1000000	usd
CY2023Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	1000000	usd
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	1000000	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	2185810	usd
CY2024Q2	us-gaap	Cash Cash	184000	usd
CY2024Q2	arat	Working Capital Deficit WorkingCapitalDeficit	397000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1448769	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	226951	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1675720	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1510	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5033332	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	169373	usd
CY2023Q4	us-gaap	Assets Assets	7147935	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	100000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	157756	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	358134	usd
CY2023Q4	us-gaap	Liabilities Liabilities	358134	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	10000	usd
CY2024Q2	us-gaap	Cash Cash	184000	usd
CY2024Q2	arat	Working Capital Deficit WorkingCapitalDeficit	397000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1448769	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	226951	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1675720	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1510	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5033332	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	169373	usd
CY2023Q4	us-gaap	Assets Assets	7147935	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	100000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100378	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	157756	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	358134	usd
CY2023Q4	us-gaap	Liabilities Liabilities	358134	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	10000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12616	usd
CY2023Q4	arat	Common Stock To Be Issue CommonStockToBeIssue	1440000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27920998	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12616	usd
CY2023Q4	arat	Common Stock To Be Issue CommonStockToBeIssue	1440000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27920998	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7147935	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	453772	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	226886	usd
	us-gaap	Gross Profit GrossProfit	453772	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	743341	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	988463	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2702448	usd
	us-gaap	Operating Expenses OperatingExpenses	2947570	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2475562	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2522688	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
CY2023Q2	arat	Other Nonoperating Income Expense One OtherNonoperatingIncomeExpenseOne	713136	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	684246	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-364383	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1791316	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2858181	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1791316	usd
	us-gaap	Profit Loss ProfitLoss	-2858181	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24564538	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17291813	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2858181	usd
	arat	Equity Based Compensation Expense Stock EquityBasedCompensationExpenseStock	1959107	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	713136	usd
	arat	Amortization Of Debt Discount Related To Derivative AmortizationOfDebtDiscountRelatedToDerivative	1047879	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	453772	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13435	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1004667	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1539010	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1539010	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	534343	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	534343	usd
	us-gaap	Notes Issued1 NotesIssued1	1091164	usd
	us-gaap	Stock Issued1 StockIssued1	18550285	usd
CY2024Q2	us-gaap	Revenues Revenues	301750	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	528636	usd
	us-gaap	Revenues Revenues	453772	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22593813	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6789801	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7147935	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	453772	usd
	us-gaap	Gross Profit GrossProfit	453772	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	743341	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	988463	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959107	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2702448	usd
	us-gaap	Operating Expenses OperatingExpenses	2947570	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2475562	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2522688	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28890	usd
CY2023Q2	arat	Other Nonoperating Income Expense One OtherNonoperatingIncomeExpenseOne	713136	usd
	arat	Other Nonoperating Income Expense One OtherNonoperatingIncomeExpenseOne	-335493	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	684246	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-364383	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1791316	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2858181	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1791316	usd
	us-gaap	Profit Loss ProfitLoss	-2858181	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24564538	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17291813	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2858181	usd
	arat	Equity Based Compensation Expense Stock EquityBasedCompensationExpenseStock	1959107	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	713136	usd
	arat	Amortization Of Debt Discount Related To Derivative AmortizationOfDebtDiscountRelatedToDerivative	1047879	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	453772	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13435	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1539010	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1539010	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	534343	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	534343	usd
	us-gaap	Notes Issued1 NotesIssued1	1091164	usd
	us-gaap	Stock Issued1 StockIssued1	18550285	usd
CY2024Q2	us-gaap	Revenues Revenues	301750	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	528636	usd
	us-gaap	Revenues Revenues	453772	usd
CY2024Q2	us-gaap	Revenues Revenues	301750	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	528636	usd
	us-gaap	Revenues Revenues	453772	usd
CY2024Q2	us-gaap	Business Combination Separately Recognized Transactions Liabilities Recognized BusinessCombinationSeparatelyRecognizedTransactionsLiabilitiesRecognized	18550285	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	110000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	58000	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	100000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	268000	usd
	us-gaap	Taxes And Licenses TaxesAndLicenses	268000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5033332	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	268000	usd
CY2024Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	55000	usd
CY2024Q2	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.10	pure
CY2024Q2	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	April 4, 2026
CY2024Q2	us-gaap	Debt Conversion Description DebtConversionDescription	the Company entered into two convertible promissory note agreements with two lenders for $20,000 each, with a total of $40,000 in proceeds received. The notes bear interest on the unpaid principal balances at a rate equal to ten percent (10%) per annum, accruing from the date of issuance until the notes become due and payable at maturity. All principal and interest accrued shall be due on April 10, 2026.
CY2024Q2	us-gaap	Revenues Revenues	301750	usd
CY2023Q2	us-gaap	Revenues Revenues	226886	usd
	us-gaap	Revenues Revenues	528636	usd
	us-gaap	Revenues Revenues	453772	usd
CY2024Q2	us-gaap	Business Combination Separately Recognized Transactions Liabilities Recognized BusinessCombinationSeparatelyRecognizedTransactionsLiabilitiesRecognized	18550285	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	110000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	58000	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	100000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	268000	usd
	us-gaap	Taxes And Licenses TaxesAndLicenses	268000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	6298452	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5033332	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	268000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	268000	usd
CY2024Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	55000	usd
CY2024Q2	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.10	pure
CY2024Q2	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	April 4, 2026
CY2024Q2	us-gaap	Debt Conversion Description DebtConversionDescription	the Company entered into two convertible promissory note agreements with two lenders for $20,000 each, with a total of $40,000 in proceeds received. The notes bear interest on the unpaid principal balances at a rate equal to ten percent (10%) per annum, accruing from the date of issuance until the notes become due and payable at maturity. All principal and interest accrued shall be due on April 10, 2026.
CY2021Q1	arat	Common Stock Issued For Loan And Compensation Expenses CommonStockIssuedForLoanAndCompensationExpenses	100000	usd
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	16166	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	83834	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126160534	shares
CY2024Q2	arat	Equity Convertible Notes Payable EquityConvertibleNotesPayable	95000	usd
	arat	Promissory Notes Stock Issued PromissoryNotesStockIssued	1100466	usd
CY2024Q2	us-gaap	Asset Acquisition Indemnification Asset Amount AssetAcquisitionIndemnificationAssetAmount	0	usd
CY2023Q4	us-gaap	Asset Acquisition Indemnification Asset Amount AssetAcquisitionIndemnificationAssetAmount	0	usd
CY2021Q1	arat	Common Stock Issued For Loan And Compensation Expenses CommonStockIssuedForLoanAndCompensationExpenses	100000	usd
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	16166	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	83834	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126160534	shares
CY2024Q2	arat	Equity Convertible Notes Payable EquityConvertibleNotesPayable	95000	usd
	arat	Promissory Notes Stock Issued PromissoryNotesStockIssued	1100466	usd
CY2024Q2	us-gaap	Asset Acquisition Indemnification Asset Amount AssetAcquisitionIndemnificationAssetAmount	0	usd
CY2023Q4	us-gaap	Asset Acquisition Indemnification Asset Amount AssetAcquisitionIndemnificationAssetAmount	0	usd

Files In Submission

Name	View Source	Status
0001753926-24-001561-index-headers.html	Edgar Link	pending
0001753926-24-001561-index.html	Edgar Link	pending
0001753926-24-001561.txt	Edgar Link	pending
0001753926-24-001561-xbrl.zip	Edgar Link	pending
arat-20240430.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g084414_10q.htm	Edgar Link	pending
g084414_ex31-1.htm	Edgar Link	pending
g084414_ex31-2.htm	Edgar Link	pending
g084414_ex32-1.htm	Edgar Link	pending
g084414_ex32-2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
arat-20240430_pre.xml	Edgar Link	unprocessable
arat-20240430_lab.xml	Edgar Link	unprocessable
g084414_10q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
arat-20240430_def.xml	Edgar Link	unprocessable
arat-20240430_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARAT
Arax Holdings Corp Stock $arat

2024 Q3 Form 10-Q Financial Statement

#000175392624001561 Filed on September 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARAT Arax Holdings Corp Stock $arat

2024 Q3 Form 10-Q Financial Statement

#000175392624001561 Filed on September 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARAT
Arax Holdings Corp Stock $arat